Risk Factors for Community-Aquired Urinary Tract Infection with ESBL-Producing Bacteria in Children
Pediatrics International,

Kizilca O et al. – Recognition of the risk factors for extended–spectrum beta–lactamases [ESBL]–producing bacteria may be helpful to determine new policies in management of urinary tract infection. These results suggest that recurrence of UTI should be prevented especially in the first year of life and prophylactic use of cephalosporins should be avoided.

Methods
  • 344 patients diagnosed as urinary tract infection between January 2008 and December 2009 were enrolled in this retrospective study.
  • Causative microorganisms were ESBL-producing in 148 patients and non–ESBL-producing in 196 patients.
  • There was no difference between the two groups regarding distribution of age, sex and follow up duration.

Results
  • The most frequent causative agents were E. coli of which 41.4 % were ESBL producing.
  • Among Klebsiella species, 53.2% were ESBL-producing.
  • The resistance rates in ESBL-producing bacteria were 83.1% for trimethoprim/sulfamethoxazole, 18.2% for nitrofurantoin, 47.3% for quinolones, 39.9% for aminoglycosides.
  • In non–ESBL-producing bacteria, the resistance rates were 62.2% for trimethoprim/sulfamethoxazole, 4.6% for nitrofurantoin, 9.7% for quinolones, 9.7% for aminoglycosides.
  • Age below 1 year, high recurrence rate of UTI, long duration of prophylaxis, using cephalosporins for prophylaxis, having been hospitalized in the past 3 months and clean intermittent catheterisation were found to be significant risk factors for ESBL poducing bacteria [p<0.05].
  • Logistic regression analysis identified age below 1 year and high recurrence rate of UTI to be independent risk factors increasing the risk 1.74 fold and 2.25 fold respectively.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Infectious Disease

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Infectious Disease Articles

1 Prolonged infusion versus intermittent boluses of β-lactam antibiotics for treatment of acute infections: A meta-analysis International Journal of Antimicrobial Agents, April 25, 2014    Review Article

2 Statins use and risk of mortality in patient with Clostridium difficile infection Clinical Microbiology and Infection, May 12, 2014    Clinical Article

3 Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America Clinical Infectious Diseases, June 20, 2014    Clinical Article

4 High doses of daptomycin (10 mg/kg/d) plus rifampin for the treatment of staphylococcal prosthetic joint infection managed with implant retention: A comparative study Diagnostic Microbiology and Infectious Disease, June 9, 2014    Clinical Article

5 Infectious causes of stroke The Lancet Infectious Diseases, May 30, 2014    Clinical Article

6 Azithromycin versus doxycycline for the treatment of genital chlamydia infection: A meta-analysis of randomized controlled trials Clinical Infectious Diseases, May 27, 2014    Evidence Based Medicine    Clinical Article

7 The efficacy of daptomycin versus vancomycin for methicillin-resistant staphylococcus aureus bloodstream infection in patients with impaired renal function Clinical Infectious Diseases, April 21, 2014    Clinical Article

8 A phase 3 randomized double-blind comparison of ceftobiprole medocaril versus ceftazidime plus linezolid for the treatment of hospital-acquired pneumonia Clinical Infectious Diseases, June 16, 2014    Clinical Article

9 Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): A randomised, double-blind, phase 3, non-inferiority trial The Lancet Infectious Diseases, June 6, 2014    Clinical Article

10 Ticks may cause double trouble, Stanford scientists find Full Text EurekAlert!, February 21, 2014    Free full text

11 2013 IDSA Clinical Practice Guideline for vaccination of the immunocompromised host Clinical Infectious Diseases, December 9, 2013    Clinical Guideline    Clinical Article

12 Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis Clinical Infectious Diseases, March 24, 2014    Clinical Article

13 Strain types and antimicrobial resistance patterns of clostridium difficile isolates from the United States, 2011 to 2013 Antimicrobial Agents and Chemotherapy, June 27, 2014    Clinical Article

14 Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: A meta-analysis Clinical Infectious Diseases, May 29, 2014    Evidence Based Medicine    Review Article

15 Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study Full Text Clinical Infectious Diseases, April 1, 2013    Free full text    Clinical Article

16 The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: A meta-analysis Journal of Viral Hepatitis, June 19, 2014    Evidence Based Medicine

17 Infections linked to Chinese seafood markets in New York The New York Times, March 7, 2014

18 The return of the big three killers Clinical Microbiology and Infection, July 30, 2013    Clinical Article

19 Comparative evaluation of the tolerability of cefazolin and nafcillin for treatment of methicillin-susceptible staphylococcus aureus infections in the outpatient setting Clinical Infectious Diseases, June 4, 2014    Clinical Article

20 Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials BMJ, June 11, 2014    Evidence Based Medicine    Clinical Article

Indexed Journals in Infectious Disease: Journal of Infection, AIDS, American Journal of Infection Controlmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close